CV Sciences (CVSI) Revenue (2013 - 2026)
CV Sciences (CVSI) reported Revenue of $3.2 million for Q1 2026, down 11.4% on a YoY basis from $3.6 million in Q1 2025, and down 3.39% sequentially from $3.3 million in Q4 2025.
CV Sciences (CVSI) Revenue (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Revenue data on file, last reported at $3.2 million in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 11.4% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (down 12.61% YoY), and the FY2025 full-year result was $13.8 million, down 12.2% from the prior year.
- Revenue retreated to $3.2 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $4.4 million in Q1 2022 to a low of $3.2 million in Q1 2026.
- A 5-year average of $3.8 million and a median of $3.9 million in 2022 frame the typical range for Revenue.
- Across the five-year window, Revenue retreated 26.55% in 2022 and advanced 9.01% in 2023, its largest moves.
- Tracing CVSI's Revenue over 5 years: stood at $3.9 million in 2022, then fell by 1.76% to $3.8 million in 2023, then rose by 2.18% to $3.9 million in 2024, then fell by 14.86% to $3.3 million in 2025, then dropped by 3.39% to $3.2 million in 2026.
- Business Quant data shows CVSI's Revenue at $3.2 million in Q1 2026, $3.3 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | CV Sciences | 4.26 Mn | 3.95 Mn | 1.56 Mn | 3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.62 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 3.95 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | 3.87 Mn |
| Sep 30, 2022 | 3.75 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 4.97 Mn |
| Sep 30, 2021 | 5.11 Mn |
| Jun 30, 2021 | 5.13 Mn |